The International Journal of Developmental Biology

Journal information and policies

The International Journal of Developmental Biology

Abrev: Int. J. Dev. Biol.

ISSN Print Edition: 0214-6282

ISSN Online Edition: 1696-3547

The International Journal of Developmental Biology is an independent, non-profit academic journal published by scientists for scientists. The journal has a long tradition (since 1952) and is published by a university press (UPV/EHU Press).

We aim to publish selected and relevant information in a specialized journal that is widely distributed among researchers in the field of developmental biology, all of this by producing a quality edition with publication options that are suitable for any researcher.

Journal information


The journal publishes works that shed light on our understanding of the mechanism of animal and plant development in health and disease and, in particular, researchs that elucidate the developmental principles underlying the properties of stem cells and cancer. Technical, historical or theoretical approaches also fall within the journal’s scope.


Editorial Service of the University of the Basque Country (UPV/EHU)

Barrio Sarriena s/n, E-48940 Leioa, Bizkaia, SPAIN


Editorial Board

Juan Arechaga
Associate Editors for THE AMERICAS
Richard Behringer
Edward M. De Robertis
Associate Editors for THE PACIFIC/ASIA
Makoto Asashima
Sally Dunwoodie
Associate Editors for EUROPE
Massimo De Felici
Brigitte Galliot
Roberto Mayor
Members of the Editorial Advisory Board
  • Peter Andrews, Sheffield (UK)
  • José A. Belo, Lisbon (Portugal)
  • Michele Boiani, Münster (Germany)
  • Ewa Borsuk, Warsaw (Poland)
  • Nigel A. Brown, London (UK)
  • Fernando Casares, Sevilla (Spain)
  • Jose Cibelli, East Lansing, MI (USA)
  • Philippe Collas, Oslo (Norway)
  • Juan Pablo Couso, Sevilla (Spain)
  • Ivan Damjanov, Kansas City, KS (USA)
  • Igor B. Dawid, Bethesda, MD (USA)
  • Eugenia Del Pino, Quito (Ecuador)
  • José de Celis, Madrid (Spain)
  • Denis Duboule, Geneva (Switzerland)
  • Ricardo Escalante, Madrid (Spain)
  • Diego Franco, Jaén (Spain)
  • Dale Frank, Haifa (Israel)
  • Stephen Gaunt, Cambridge (UK)
  • Scott F. Gilbert, Swarthmore, PA (USA)
  • John B. Gurdon, Cambridge (UK)
  • Alicia Hidalgo, Birmingham (UK)
  • Marie C. Hofmann, Houston, TX (USA)
  • Nick Hopwood, Cambridge (UK)
  • Juan C. Izpisua-Belmonte, La Jolla, CA (USA)
  • Thierry Jaffredo, Paris (France)
  • Zbynek Kozmik, Prague (Czech Republic)
  • Jazek Z. Kubiak, Rennes (France)
  • Marek Maleszewski, Warsaw (Poland)
  • Moisés Mallo, Oeiras (Portugal)
  • Marc Mareel, Gent (Belgium)
  • Artur Mayerhofer, Munich (Germany)
  • José Luis Micol, Alicante (Spain)
  • Sally A. Moody, Washington DC (USA)
  • Marc Moreau, Toulouse (France)
  • Ramón Muñoz Chápuli, Málaga (Spain)
  • Stefan Nonchev, Grenoble (France)
  • Roger A. Pedersen, Cambridge (UK)
  • Günter Plickert, Köln (Germany)
  • Carlo A. Redi, Pavia (Italy)
  • Wolf Reik, Cambridge (UK)
  • Domenico Ribatti, Bari (Italy)
  • M. Angeles Ros, Santander (Spain)
  • Emili Saló, Barcelona (Spain)
  • Lucas Sánchez, Madrid (Spain)
  • Paul Sharpe, London (UK)
  • Antonio Simeone, Naples (Italy)
  • Michael J. Soares, Kansas City, KS (USA)
  • Claudio Stern, London (UK)
  • Colin Stewart, Singapore
  • Miguel Torres, Madrid (Spain)
  • Maurizio Zuccotti, Parma (Italy)

Impact and Indexing

The journal is indexed in the most important articles and journals databases. Here are some of the most relevant ones:

JCR (Clarivate Analytics): 2021 IF 2.148; 2021 Cites 4,517
Scimago (Scopus): 2021 H Index 107
Google Scholar Metrics (Google): 2021 h5-index 17

PubMed (National Library of Medicine), MEDLINE (National Library of Medicine), Web of Science (Clarivate Analytics), Science Citation Index (Clarivate Analytics), Scopus (Elsevier), Google Scholar (Google), BIOSIS (Clarivate Analytics), Embase (Elsevier), WorldCat (OCLC)…

Journal policies

Open Access and Copyright policies

Authors can publish their manuscript at no cost under an embargoed publication model (12 months) or pay a fee and make their article Open Access (Gold Open Access). By choosing this Gold Open Access option, the article is published with immediate free access and the authors own the copyright under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Regardless of the model chosen by the authors, depending on their preferences or needs, and whether they pay a fee or not, all articles are published at the time of acceptance as "Accepted Article". This raw version (without formatting or copyediting, but with the latest changes incorporated after the review process), will be published under a CC BY 4.0 license. As such, the authors have permission to publish it, with immediate free access, in the repository of their choice.

The authors make the choice of the publication model after the manuscript is accepted, so it is guaranteed that it does not have any influence on the review phase.

Funders’ compliance

Whether the authors choose to publish in Gold Open Access for a fee or not, the publication complies with the mandates of funding agencies, as such as those following the guidelines of Plan S from cOAlition S and others.

If the authors choose to pay for Open Access, as it is not a fully Open Access journal (it is a hybrid journal), it is possible that the funder may not cover these Open Access publication costs. If this is the case, the authors can inform, and the journal will compensate for this inconvenience. The journal will try to avoid any circumstance unrelated to the content of the manuscript that may condition the authors’ choice of publishing their work.

We recommend checking the funders’ requirements and asking the journal staff in case of any doubt or if any kind of assistance is needed.

Plan S from cOAlition S

We comply fully with the open access requirements of cOAlition S, UKRI, Wellcome, and NIHR. Where required by their funder, authors retain the right to distribute their author accepted manuscript (AAM), such as via an institutional and/or subject repository (e.g. EuropePMC), under a Creative Commons Attribution 4.0 International (CC BY 4.0) licence for release no later than the date of first online publication.

NIH Public Access Policy and PubMed Central (PMC) / Europe Pubmed Central (Europe PMC) partners

The journal complies with the NIH Public Access Policy and PMC partners. Authors using these public or institutional funds must deposit either the final version of the manuscript (if paid for Gold Open Access) or the author accepted manuscript (AAM) to PubMed Central upon acceptance.


The journal allows the submission of manuscripts that have been posted to preprint servers. Once published, the DOI of the final published version of the article should be indicated on the preprint.

Peer Review

Once the manuscript has been submitted, it will receive a quick evaluation by the Editor-in-Chief and/or the editorial board of the journal. In the event that it is not considered suitable because it does not fit the scope of the journal or some similar aspect, a rapid response will be given. If it passes this first evaluation, the manuscript will be sent to the reviewers who will carry out their evaluation.

All manuscripts mentioning research results, theories or conclusions, own or from other works (Original Articles, Reviews, Technical Articles, Developmental Expression Patterns, Essays, etc.), are peer-reviewed. Manuscripts on different topics (editorials, some interviews, meeting reports, introductory articles of special issues...) are not peer-reviewed. Still, they will be reviewed by the Editor-in-Chief and/or editorial board members. The type of Peer Review carried out by the journal is: “Single-blind peer review”. It is the most common. The reviewers remain anonymous but may know the identity of the authors of the paper.

Publication fees

The journal publishes the manuscripts without any kind of publication cost for the authors. Additionally, authors can select optional paid services if they wish. These services and their rates are as follows:

  • Publication: Free
  • Open Access (optional): 500 euro
  • Printed copy of regular issue (optional): 40 euro (additional copies 35 euro)
  • Printed copy of special issue (optional): 70 euro (additional copies 65 euro)

Additionally, authors from subscribing institutions can benefit from a 10% discount on these optional services (Open Access and printed copies).

Timely publication

Once the manuscript has been submitted, it will receive a quick evaluation by the Editor-in-Chief and/or the editorial board of the journal. In the event that it is not considered suitable because it does not fit the scope of the journal or some similar aspect, a rapid response will be given. The maximum time that this first evaluation can take is usually one week.

In the case of being sent for review, it will depend on the ease of finding reviewers suitable for the content of the manuscript and their availability. The process usually takes about 3 or 4 weeks.

If no major revisions by the author are necessary, the "Accepted Article" would be published online within a month of submission, on average.

In the case of special issues, these times may vary. You can consult us personally in each case at .

Ethics policies

Conflict of Interest Statement

Authors must declare any potential conflict of interest in the manuscript. This statement must reflect any aspect (financial or otherwise) that could influence the results or conclusions of the work.

If no conflict occurs, it must also be explicitly specified. Typically, a phrase such as: “The Authors declare that they have no conflict of interest” is included.

Authors’ contributions

It is recommended that the contribution of each author in the preparation of the work be clarified.

Plagiarism and Image Manipulation

Authors must ensure that all written material, images or any other previously published format are correctly cited in the text and reference section. Unless expressly justified, it is not allowed to include verbatim or parts of text from other publications. The journal will reject the manuscript, and we will take the appropriate measures in case of detecting this type of practice with the technological tools at its disposal.

Authors must obtain the necessary permissions to reuse or adapt parts of other publications (usually images) and to attribute their authorship properly.

Of course, fraudulent manipulation of images, tables or any other type of material with the aim of altering the results or conclusions of the manuscript is not permitted. If this type of manipulation is detected, the journal will reject the work without prejudice to taking other kinds of measures.

Experimentation with humans and animals

All works that carry out experimentation with humans or animals must comply with the ethical standards of the relevant national and international institutions and this must be stated in the work.

In the case of studies involving human participants, the ethics committee that approved the study must be stated that the informed consent of the participants was obtained in the circumstances in which it is applicable.

Manuscript preparation and submission

We want the manuscript submission process to be simple. The submission system is fast, with no long forms to fill out, and no special formatting of the manuscript or references is required to be evaluated. For more information see our guide for authors.